These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12401662)

  • 1. An update of new targets for cancer treatment: vessels and matrix.
    Bicknell R
    Ann Oncol; 2002; 13 Suppl 4():25-8. PubMed ID: 12401662
    [No Abstract]   [Full Text] [Related]  

  • 2. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivascular therapies: targets beyond the vessel wall.
    Temming K; Kok RJ
    ChemMedChem; 2007 Apr; 2(4):433-5. PubMed ID: 17315256
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion - anti-VEGF agents.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S135-7. PubMed ID: 18520297
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents.
    Ma BB; Bristow RG; Kim J; Siu LL
    J Clin Oncol; 2003 Jul; 21(14):2760-76. PubMed ID: 12860956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoplasms under control with the help of vascular treatment?].
    Laurén J; Alitalo K
    Duodecim; 2000; 116(7):705-11. PubMed ID: 12078136
    [No Abstract]   [Full Text] [Related]  

  • 8. Future directions with angiogenesis inhibitors in colorectal cancer.
    Bilenker JH; Haller DG
    Clin Colorectal Cancer; 2004 Oct; 4 Suppl 2():S86-93. PubMed ID: 15479485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.
    Jain RK
    Nat Med; 2001 Sep; 7(9):987-9. PubMed ID: 11533692
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis: health and disease.
    Bikfalvi A
    Ann Oncol; 2006 Sep; 17 Suppl 10():x65-70. PubMed ID: 17018754
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis.
    Christopoulos A; Ahn SM; Klein JD; Kim S
    Head Neck; 2011 Aug; 33(8):1220-9. PubMed ID: 21755565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking down tumors: vascular disrupting agents entering clinical trials.
    O'Hanlon LH
    J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiogenesis inhibitors: from laboratory to clinical application.
    Nakamura T; Matsumoto K
    Biochem Biophys Res Commun; 2005 Jul; 333(2):289-91. PubMed ID: 15953588
    [No Abstract]   [Full Text] [Related]  

  • 14. VEGF-A: a critical regulator of blood vessel growth.
    Ferrara N
    Eur Cytokine Netw; 2009 Dec; 20(4):158-63. PubMed ID: 20167554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels - a pharmacodynamic study.
    Zhang D; Pier T; McNeel DG; Wilding G; Friedl A
    Invest New Drugs; 2007 Feb; 25(1):49-55. PubMed ID: 17001523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-angiogenic treatment is effective for treating metastatic colorectal cancers].
    Bono P; Joensuu H
    Duodecim; 2004; 120(3):261-2. PubMed ID: 15061003
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to anti-angiogenesis: an ever changing feature.
    Bertolini F
    Breast; 2011 Oct; 20 Suppl 3():S61-2. PubMed ID: 22015295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy: An elusive cancer target.
    Brown C
    Nature; 2016 Sep; 537(7620):S106-8. PubMed ID: 27626779
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
    Ferrara N; Hillan KJ; Novotny W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
    Osada H; Kakeya H
    Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.